Chronic coronary disease (stable IHD)

chronic-coronary-disease · society: AHA/ACC

← back to Cardiology

Summary

Comprehensive update consolidating evidence since the 2012/2014 stable ischemic heart disease guidelines for outpatient management of chronic coronary disease (CCD). Emphasizes team-based, patient-centered care with shared decision-making, social determinants of health, and cost/value considerations. Key new directions: limited role for long-term beta blockers without MI/LVEF≤50%, expanded use of SGLT2 inhibitors and GLP-1 RAs (including some without diabetes), shorter DAPT durations when bleeding risk is high, low-dose colchicine as adjunct, and recommendation against routine periodic ischemic/anatomic testing in stable asymptomatic patients.

Current guideline: 2023 AHA/ACC Multisociety Chronic Coronary Disease Guideline · download Anki sub-deck

Versions


Table of contents